Taiho buys Swiss biotech and its ADC tech for $400M

The pharma will acquire Araris Biotech to gain access to a trio of preclinical ADCs and a linking technology Araris claims is superior to conventional platforms.

Mar 17, 2025 - 17:18
 0
Taiho buys Swiss biotech and its ADC tech for $400M

The pharma will acquire Araris Biotech to gain access to a trio of preclinical ADCs and a linking technology Araris claims is superior to conventional platforms.